Critical Molecular and Cellular Contributors to Tau Pathology

Tauopathies represent a group of neurodegenerative diseases including Alzheimer’s disease (AD) that are characterized by the deposition of filamentous tau aggregates in the brain. The pathogenesis of tauopathies starts from the formation of toxic ‘tau seeds’ from hyperphosphorylated tau monomers. Th...

Full description

Bibliographic Details
Main Authors: Liqing Song, Evan A. Wells, Anne Skaja Robinson
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/2/190
_version_ 1797396527340060672
author Liqing Song
Evan A. Wells
Anne Skaja Robinson
author_facet Liqing Song
Evan A. Wells
Anne Skaja Robinson
author_sort Liqing Song
collection DOAJ
description Tauopathies represent a group of neurodegenerative diseases including Alzheimer’s disease (AD) that are characterized by the deposition of filamentous tau aggregates in the brain. The pathogenesis of tauopathies starts from the formation of toxic ‘tau seeds’ from hyperphosphorylated tau monomers. The presence of specific phosphorylation sites and heat shock protein 90 facilitates soluble tau protein aggregation. Transcellular propagation of pathogenic tau into synaptically connected neuronal cells or adjacent glial cells via receptor-mediated endocytosis facilitate disease spread through the brain. While neuroprotective effects of glial cells—including phagocytotic microglial and astroglial phenotypes—have been observed at the early stage of neurodegeneration, dysfunctional neuronal-glial cellular communication results in a series of further pathological consequences as the disease progresses, including abnormal axonal transport, synaptic degeneration, and neuronal loss, accompanied by a pro-inflammatory microenvironment. Additionally, the discovery of microtubule-associated protein tau (<i>MAPT</i>) gene mutations and the strongest genetic risk factor of tauopathies—an increase in the presence of the ε2 allele of apolipoprotein E (<i>ApoE</i>)—provide important clues to understanding tau pathology progression. In this review, we describe the crucial signaling pathways and diverse cellular contributors to the progression of tauopathies. A systematic understanding of disease pathogenesis provides novel insights into therapeutic targets within altered signaling pathways and is of great significance for discovering effective treatments for tauopathies.
first_indexed 2024-03-09T00:52:41Z
format Article
id doaj.art-896957f224ad4023982ed31b99ffa464
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T00:52:41Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-896957f224ad4023982ed31b99ffa4642023-12-11T17:05:49ZengMDPI AGBiomedicines2227-90592021-02-019219010.3390/biomedicines9020190Critical Molecular and Cellular Contributors to Tau PathologyLiqing Song0Evan A. Wells1Anne Skaja Robinson2Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USADepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USADepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USATauopathies represent a group of neurodegenerative diseases including Alzheimer’s disease (AD) that are characterized by the deposition of filamentous tau aggregates in the brain. The pathogenesis of tauopathies starts from the formation of toxic ‘tau seeds’ from hyperphosphorylated tau monomers. The presence of specific phosphorylation sites and heat shock protein 90 facilitates soluble tau protein aggregation. Transcellular propagation of pathogenic tau into synaptically connected neuronal cells or adjacent glial cells via receptor-mediated endocytosis facilitate disease spread through the brain. While neuroprotective effects of glial cells—including phagocytotic microglial and astroglial phenotypes—have been observed at the early stage of neurodegeneration, dysfunctional neuronal-glial cellular communication results in a series of further pathological consequences as the disease progresses, including abnormal axonal transport, synaptic degeneration, and neuronal loss, accompanied by a pro-inflammatory microenvironment. Additionally, the discovery of microtubule-associated protein tau (<i>MAPT</i>) gene mutations and the strongest genetic risk factor of tauopathies—an increase in the presence of the ε2 allele of apolipoprotein E (<i>ApoE</i>)—provide important clues to understanding tau pathology progression. In this review, we describe the crucial signaling pathways and diverse cellular contributors to the progression of tauopathies. A systematic understanding of disease pathogenesis provides novel insights into therapeutic targets within altered signaling pathways and is of great significance for discovering effective treatments for tauopathies.https://www.mdpi.com/2227-9059/9/2/190tauopathiesAlzheimer’s diseaseprion-like propagationtau self-aggregationendocytosisneuron-glial communication
spellingShingle Liqing Song
Evan A. Wells
Anne Skaja Robinson
Critical Molecular and Cellular Contributors to Tau Pathology
Biomedicines
tauopathies
Alzheimer’s disease
prion-like propagation
tau self-aggregation
endocytosis
neuron-glial communication
title Critical Molecular and Cellular Contributors to Tau Pathology
title_full Critical Molecular and Cellular Contributors to Tau Pathology
title_fullStr Critical Molecular and Cellular Contributors to Tau Pathology
title_full_unstemmed Critical Molecular and Cellular Contributors to Tau Pathology
title_short Critical Molecular and Cellular Contributors to Tau Pathology
title_sort critical molecular and cellular contributors to tau pathology
topic tauopathies
Alzheimer’s disease
prion-like propagation
tau self-aggregation
endocytosis
neuron-glial communication
url https://www.mdpi.com/2227-9059/9/2/190
work_keys_str_mv AT liqingsong criticalmolecularandcellularcontributorstotaupathology
AT evanawells criticalmolecularandcellularcontributorstotaupathology
AT anneskajarobinson criticalmolecularandcellularcontributorstotaupathology